Inhibrx Biosciences, Inc.INBXNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-100.00%
↓ 225% below average
Average (30q)
80.06%
Historical baseline
Range
High:1273.11%
Low:-100.00%
Volatility
1715.0%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -100.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | -100.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | -100.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | -100.00% |
| Q4 2023 | 1273.11% |
| Q3 2023 | 296.67% |
| Q2 2023 | 76.47% |
| Q1 2023 | -93.80% |
| Q4 2022 | -1.44% |
| Q3 2022 | -60.90% |
| Q2 2022 | -22.30% |
| Q1 2022 | -67.74% |
| Q4 2021 | 13.08% |
| Q3 2021 | 173.20% |
| Q2 2021 | 6.37% |
| Q1 2021 | -68.91% |
| Q4 2020 | -52.35% |
| Q3 2020 | 74.75% |
| Q2 2020 | 282.34% |
| Q1 2020 | 226.59% |
| Q4 2019 | -66.37% |
| Q3 2019 | -20.60% |
| Q2 2019 | -85.78% |
| Q1 2019 | 209.92% |
| Q4 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 789.68% |
| Q4 2017 | 0.00% |